| Year | Deal partners | Asset / target | Modality | Deal type | Deal value | Stage at deal | Category |
|---|
Oncology & macrophage deals — antibody modality, preclinical / Phase 1 focus. Five-year view.
| Year | Deal partners | Asset / target | Modality | Deal type | Deal value | Stage at deal | Category |
|---|